MycoWorks, Inc.

Biomaterials Leader Strengthens Financial, Legal and Technology Expertise As It Scales to Meet Demand EMERYVILLE, Calif., Aug. 22, 2023 /PRNewswire/ -- Today, biomaterials technology company MycoWorks announced the appointment of three executives to its leadership team. The news of these strategic additions comes just weeks ahead of the September 20, 2023 opening of the company's first commercial-scale Fine Mycelium™ production facility in Union, South Carolina. "The news of these executive appointments comes at a time of significant growth and achievement for MycoWorks," said Matt Scullin, CEO of MycoWorks. "We are committed to growing the future of luxury materials and the addition of these accomplished leaders strengthens our position today and tomorrow." Juan Lopez, Chief Financial Officer (CFO): With two decades of experience as a Finance and Sales Operations executive, Juan Lopez joins MycoWorks as the new CFO. He brings experience in both industrial and consumer goods sectors, delivering outstanding value through process improvement & optimization, and scale up of ventures. Most recently, he was the Chief Financial Officer and Chief Operating Officer of the Biotech Business Unit at Anheuser-Busch Inbev, focused on developing and commercializing alternative proteins and food ingredients through biotechnology. Craig Fleishman, General Counsel (GC): Craig Fleishman brings 20 years' experience advising prominent public figures and brands, including JPMorgan, Maersk, Lady Gaga, Oprah Winfrey and Masterclass, and two U.S. Presidents. He joined MycoWorks after a long tenure as General Counsel and Head of Corporate Development for Rebecca Minkoff where he drove the brand's industry-leading innovation pipeline, and developed the brand's unique global IP strategy. He has taught as an adjunct law professor, and worked at two of the world's top law firms and in-house at a global private equity firm where his portfolio included both luxury and sustainable technology companies. Maud Ohler, Vice President of Technology Development: With a PhD in fermentation science and a decade of experience in international industrial biotech, Maud Ohler joins Mycoworks as the Vice President of Technology Development. Her industrial experience from Evolva, Amyris, and Zymergen has spanned strain and fermentation process development, technology transfer and scale-up, and R&D team management supporting achievement of project goals for new products. To learn more about employment opportunities at MycoWorks, visit About MycoWorks In 2013, co-founders Philip Ross and Sophia Wang formed MycoWorks, a San Francisco-based biomaterials company dedicated to bringing new mycelium-grown materials to the world. MycoWorks' patented Fine Mycelium™ technology, an advanced manufacturing platform and breakthrough in materials science, engineers mycelium during growth to form proprietary, interlocking cellular structures for unparalleled beauty, handfeel, strength and durability. The company's flagship material- Reishi™ - is a new category of material for the world's best luxury brands. For more information, please visit mycoworks.com and madewithreishi.com. CONTACT: [email protected] SOURCE MycoWorks

Heron Preston set to launch a range of designs made with Reishi™ in 2023 EMERYVILLE, Calif., Dec. 12, 2022 /PRNewswire/ -- Today, artist, creative director, and designer Heron Preston debuted an art piece inspired by and designed with MycoWorks' innovative mycelium material, Reishi™: A Fruit Bowl by Heron Preston for MycoWorks, which will be available exclusively on a new digital platform by Heron Preston that will launch early next year. The inimitable, one edition only piece represents the first of many product launches between Heron Preston and MycoWorks. Biotechnology company MycoWorks was originally founded by artists who pioneered the use of mycelium and other living materials to grow and create art. MycoWorks has since developed, commercialized, and scaled its flagship material, Reishi™ – a unique, flexible, durable material that emulates the handfeel of animal leather but is made entirely from mycelium, the infinitely renewable root structure of mushrooms. Born out of a joint appreciation for the sensory attributes and limitless design possibilities of mycelium and Reishi™, A Fruit Bowl by Heron Preston for MycoWorks will be exclusively available as part of Heron's soon-to-launch, digital platform focused on L.E.D. (Less Environmentally Destructive) concepts and how they can take shape in culturally relevant and relatable ways. Heron Preston said: "A fruit bowl is usually one of the first objects that painters depict to demonstrate their skills and understanding of the medium. And this is an exercise on how this material (Fine Mycelium), through my lens is getting its start - as a fruit bowl. A material with endless possibilities and applications, like a painting. The fruit made of Fine Mycelium messages new beginnings and a future not bound by our past, but pushed forward through our imagination and human ingenuity; a breakthrough in materials science and biotechnology." Sophia Wang, MycoWorks Co-Founder & Chief of Culture said: "Given MycoWorks' roots in art, this partnership with Heron Preston represents our company's enduring values of thoughtful design and aesthetics, wide-ranging inspiration, and visionary imagination. Over the last decade, MycoWorks has grown to over 160 employees and produces tens of thousands of sheets of material per year, but these values have and will always hold true." Heron Preston will continue to craft and launch a range of designs made with Reishi™ in 2023. Hi-res images of A Fruit Bowl by Heron Preston for MycoWorks can be found here. About MycoWorks: In 2013, co-founders Philip Ross and Sophia Wang founded MycoWorks, a San Francisco-based biomaterials company dedicated to bringing new mycelium materials to the world. MycoWorks' patented Fine Mycelium™ technology, an advanced manufacturing platform and breakthrough in materials science, engineers mycelium during growth to form proprietary, interlocking cellular structures for unparalleled strength and durability. Fine Mycelium™ refers both to MycoWorks' proprietary process and to a new category of materials used in the fashion, footwear, automotive, and decor industry that are exclusive to MycoWorks. MycoWorks flagship Fine Mycelium™ product, Reishi™ is a premium, natural material that offers the quality, hand feel, and performance of the finest animal leathers with lower environmental impact and unprecedented freedom to customize. For more information, please visit mycoworks.com and madewithreishi.com. Media Contact: Lauren Daum [email protected] SOURCE MycoWorks

Collaboration will use MycoWorks' proprietary Fine Mycelium technology to explore use of non-animal materials in automotive design EMERYVILLE, Calif., Oct. 18, 2022 /PRNewswire/ -- Biotechnology company MycoWorks announced today its newest investor GM Ventures, the investment arm of General Motors Co. (NYSE: GM), and their long-term agreement to co-develop Fine Mycelium™ materials for potential use in a range of applications within automotive design. MycoWorks' collaboration with GM marks the exploration of its entry into one of the largest end-use markets for leather and demonstrates the significant opportunity to create more sustainable materials for the automotive space. MycoWorks' breakthrough Fine Mycelium technology engineers mycelium, the infinitely renewable root structure of mushrooms, to craft a range of natural, customizable leather alternatives that match the performance of the highest quality animal leather with lower environmental impact. The company's platform has enabled a new class of premium, non-animal materials which could have the opportunity to support GM's continued progress toward its vision of a world with zero crashes, zero emissions and zero congestion. Animal-free and chrome-free, Fine Mycelium also has superior strength at low thicknesses, offering a compelling pathway to efficiency and weight reduction in car interiors while still meeting the most stringent performance, aesthetic, and environmental requirements of the automotive space. "Working with General Motors to introduce Fine Mycelium to the automotive industry is an enormous step forward in the global new materials revolution," said Matt Scullin, CEO of MycoWorks. "MycoWorks's collaboration with GM is a first for us outside of the fashion industry, demonstrating the enormous potential and applications for Fine Mycelium." "Our strategic investment in MycoWorks aims to advance the development of sustainable automotive materials," said Wade Sheffer, managing director of GM Ventures. "This collaboration will help facilitate R&D efforts and build more sustainable alternatives for our designers." In August 2022, following an oversubscribed $125M Series C funding round, MycoWorks broke ground on its first full-scale production facility, which will enable initial mass-production volumes of several million square feet of Fine Mycelium materials per year, dramatically increase production and partnership capacity, and service Fine Mycelium to a wider range of industries and companies. About MycoWorks In 2013, co-founders Philip Ross and Sophia Wang formed MycoWorks, a San Francisco-based biomaterials company dedicated to bringing new mycelium materials to the world. MycoWorks' patented Fine Mycelium technology, an advanced manufacturing platform and breakthrough in materials science, engineers mycelium during growth to form proprietary, interlocking cellular structures for unparalleled strength and durability. For more information, please visit mycoworks.com. About General Motors General Motors (NYSE: GM) is a global company focused on advancing an all-electric future that is inclusive and accessible to all. At the heart of this strategy is the Ultium battery platform, which powers everything from mass-market to high-performance vehicles. General Motors, its subsidiaries and its joint venture entities sell vehicles under the Chevrolet, Buick, GMC, Cadillac, Baojun and Wuling brands. More information on the company and its subsidiaries can be found at . Media Contact: Leah Lefco [email protected] SOURCE MycoWorks